GlassScriptPhysician profile
Curtis P Craig
NPI 1255392361
$2,791.59
in general payments reported to CMS, 2019-2025
34 companies · $899 in 2025
The $899 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2021: $99.99 · 2022: $170 · 2023: $264 · 2024: $230 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.63 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $706.79 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $274.98 | 2019-2025 | |
| Lilly USA, LLC | $191.57 | 2019-2025 | Jardiance, Kisunla |
| Astrazeneca Pharmaceuticals LP | $135.37 | 2019-2025 | Airsupra |
| Amgen INC. | $127.71 | 2019-2025 | Otezla, Repatha |
| Allergan, INC. | $115.38 | 2019 | |
| Edwards Lifesciences Corporation | $103.57 | 2019 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.49 | 2019 | |
| Exact Sciences Corporation | $82.43 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Currax Pharmaceuticals LLC | $75.00 | 2023 | Nexletol |
| Glaxosmithkline, LLC. | $64.44 | 2019-2025 | Shingrix, Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $63.56 | 2019 | |
| Supernus Pharmaceuticals, INC. | $50.34 | 2024-2025 | Qelbree |
| Merck Sharp & Dohme LLC | $48.83 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $46.79 | 2023 | Interstim |
| Novartis Pharmaceuticals Corporation | $42.32 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $41.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.84 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.08 | 2025 | Xifaxan |
| Esperion Therapeutics, INC. | $36.50 | 2023-2025 | Nexletol |
| Amarin Pharma, INC. | $36.05 | 2019 | |
| Seqirus USA INC | $34.92 | 2025 | Fluad, Flucelvax |
| Abiomed | $31.32 | 2025 | |
| Arbor Pharmaceuticals, INC. | $26.28 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $26.01 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $24.83 | 2019 | |
| Axsome Therapeutics, INC. | $22.05 | 2025 | Auvelity |
| Abbvie INC. | $17.51 | 2025 | |
| Jazz Pharmaceuticals INC. | $15.94 | 2019 | |
| Bausch Health US, LLC | $15.10 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.58 | 2025 | Rexulti |
| Shire North American Group INC | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.